Financial Counselors Inc Abbott Laboratories Transaction History

Financial Counselors Inc

$6.67 Billion
Q3 2024

A detailed history of Financial Counselors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Counselors Inc holds 51,903 shares of ABT stock, worth $6.82 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

51,903

Previous 52,075 0.33%

Holding current value

$6.82 Million

Previous $5.41 Million 9.35%

% of portfolio

0.09%

Previous 0.09%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $17,212 - $20,318	-172 Reduced 0.33%	51,903 $5.92 Million
Q2 2024 Aug 01, 2024	SELL	$100.73 - $112.44 $174,162 - $194,408	-1,729 Reduced 3.21%	52,075 $5.41 Million
Q1 2024 May 02, 2024	BUY	$109.52 - $120.96 $92,434 - $102,090	844 Added 1.59%	53,804 $6.12 Million
Q4 2023 Jan 26, 2024	BUY	$90.19 - $110.4 $86,943 - $106,425	964 Added 1.85%	52,960 $5.83 Million
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $28,181 - $33,812	-295 Reduced 0.56%	51,996 $5.04 Million
Q2 2023 Jul 27, 2023	SELL	$100.78 - $112.29 $7,457 - $8,309	-74 Reduced 0.14%	52,291 $5.7 Million
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $364,581 - $429,133	-3,764 Reduced 6.71%	52,365 $5.3 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $228,334 - $267,871	2,402 Added 4.47%	56,129 $6.16 Million
Q3 2022 Nov 01, 2022	SELL	$96.76 - $112.03 $524,342 - $607,090	-5,419 Reduced 9.16%	53,727 $5.2 Million
Q2 2022 Aug 02, 2022	BUY	$102.07 - $123.37 $639,774 - $773,283	6,268 Added 11.85%	59,146 $6.43 Million
Q1 2022 Apr 28, 2022	BUY	$114.02 - $139.04 $845,686 - $1.03 Million	7,417 Added 16.32%	52,878 $6.26 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $2.68 Million - $3.29 Million	-23,226 Reduced 33.81%	45,461 $6.4 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $115,376 - $127,640	-989 Reduced 1.42%	68,687 $8.11 Million
Q2 2021 Aug 03, 2021	BUY	$105.79 - $124.53 $200,154 - $235,610	1,892 Added 2.79%	69,676 $8.08 Million
Q1 2021 Apr 29, 2021	SELL	$108.84 - $128.23 $18,720 - $22,055	-172 Reduced 0.25%	67,784 $8.12 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $238,140 - $259,504	-2,268 Reduced 3.23%	67,956 $7.44 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $728,263 - $884,421	-7,947 Reduced 10.17%	70,224 $7.64 Million
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $2.45 Million - $3.13 Million	31,943 Added 69.1%	78,171 $7.15 Million
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $150,642 - $220,280	-2,398 Reduced 4.93%	46,228 $3.65 Million
Q4 2019 Jan 31, 2020	BUY	$78.51 - $87.4 $549 - $611	7 Added 0.01%	48,626 $4.22 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $65,881 - $71,435	-805 Reduced 1.63%	48,619 $4.07 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $59,397 - $69,275	-815 Reduced 1.62%	49,424 $4.16 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $350,502 - $423,757	-5,293 Reduced 9.53%	50,239 $4.02 Million
Q4 2018 Feb 01, 2019	SELL	$65.56 - $74.27 $142,527 - $161,462	-2,174 Reduced 3.77%	55,532 $4.02 Million
Q3 2018 Oct 30, 2018	SELL	$60.81 - $73.36 $23,898 - $28,830	-393 Reduced 0.68%	57,706 $4.23 Million
Q2 2018 Aug 03, 2018	SELL	$57.57 - $63.54 $26,885 - $29,673	-467 Reduced 0.8%	58,099 $3.54 Million
Q1 2018 Apr 26, 2018	SELL	$56.27 - $63.62 $240,723 - $272,166	-4,278 Reduced 6.81%	58,566 $3.51 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $121,370 - $129,939	2,261 Added 3.73%	62,844 $3.59 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $96,071 - $107,226	1,999 Added 3.41%	60,583 $3.23 Million
Q2 2017 Aug 10, 2017	BUY	N/A	58,584	58,584 $2.85 Million

Others Institutions Holding ABT

# of Institutions

3,265

Shares Held

1.31B

Call Options Held

9.64M

Put Options Held

8.27M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $230B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account

Financial Counselors Inc Abbott Laboratories Transaction History